Home

Peter Heerma, Chief Commercial Officer: Travere Therapeutics TVTX Sell · Filed 25/10/30

Trade details

Type
Insider sale
Amount
$79,860
Shares · price
2,662 sh · $30.00 a share
Held after
124,662 sh
Trade date
25/10/28
Filed
25/10/30
Days to filing
2 days

Sold 2.1% of holdings

Share of holding sold
2.1%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/28~25/11/27

Peter Heerma's recent trades

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $525.7K

    Filed 09/17

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $10.8M

    Filed 09/16

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $6.7M

    Filed 09/15

  • Peter Heerma

    SellTravere Therapeutics

    $101.4K

    Filed 05/06

  • Peter Heerma

    Planned saleTravere Therapeutics

    $101.4K

    Filed 05/05